Company News-Bio-Thera Solutions, Ltd.

2026-02-13

• European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera ...

查看详情

12-242024

Bio-Thera Solutions Partners with Tabuk Pharmaceuticals to Commercialize BAT2206, a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia

Guangzhou, China, December 24, 2024 - Bio-TheraSolutions Inc.(688177:SH),a commercial-stage biopharmaceutical company de...
12-162024

Bio-Thera Solutions Expands Partnership with SteinCares in LATAM with Addition of a Third Biosimilar to Partnership

GUANGZHOU, China - Bio-Thera Solutions, a commercial-stage biopharmaceutical companydeveloping innovative therapies and ...
10-092024

Bio-Thera and Richter Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, for EU countries, UK, Switzerland and other selected countries

Guangzhou, China/Budapest, Hungary– # October 9,2024 – Bio-Thera Solutions (688177:SH; “Bio-Thera”), a commercial-stageb...